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from brachial BP and may be a superior predictor of
cardiovascular events. However, its measurement is
currently restricted to research settings, owing to a
moderate level of operator dependency. We tested a new
noninvasive device in a large UK cohort. The device
estimates central BP using measurements obtained with an
upper arm cuff inflated to suprasystolic pressure. We
compared these estimates with those obtained using radial
tonometry as well as with invasively acquired
measurements of aortic BP in a limited number of
individuals.
Methods: Consecutive cuff-based and tonometry-based
estimates of the pressure waveform and the central BP
were obtained from 1107 individuals (70 6 years). Short-
term and long-term reproducibility studies were performed
on 28 individuals. Simultaneous cuff-based and invasively
measured pressure traces were acquired and compared in
an additional six individuals (6520 years).
Results: Central systolic BP, as estimated by the cuff-
based device, was found to be highly reproducible
(coefficient of variation 4 and 8% for short and long-term
reproducibility, respectively) and was comparable to that
estimated by tonometry (average difference 3 6 mmHg,
intraclass correlation coefficient¼0.91). The cuff-based
pressure waveforms were similar to those acquired
invasively (cross-correlation coefficient 0.93), and the
difference in the estimated central systolic BP was
58 mmHg (P¼ 0.2).
Conclusion: Cuff-based devices show promise to simplify
the measurement of central BP, whilst maintaining a
similar fidelity to tonometry. This could lead to improved
adoption of estimates of central BP in clinical practice.
Keywords: brachial cuff, central blood pressure, invasive,
noninvasive, tonometry
Abbreviations: AMMI, American Association for the
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ypertension is a major determinant of cardiovas-
cular disease (CVD) [1], and measurement of blood
pressure (BP) using a brachial cuff is one of the
most widely performed clinical investigations. Systolic and
diastolic BP are determined by the shape of the BP wave-
form, which is itself influenced by the interaction between
left ventricular ejection and the biomechanical properties of
the arterial system. Pulse pressure increases as it travels
from the aorta to peripheral locations such as the brachial
artery [2], and the difference between aortic and brachial
systolic BP (bSBP) can be substantial [3]. In adults, periph-
eral systolic BP exceeds aortic pressure by approximately
10mmHg; however, this difference can be much greater
especially in younger individuals and with increased heart
rate. Differences between central (aortic) and brachial BP
could be clinically important, as central BP is more closely
correlated with target organ damage in hypertension [4]; is
differentially influenced by antihypertensive therapy com-
pared with brachial BP [5]; and may be a superior predictor
of cardiovascular events than brachial BP [6]. These three
factors emphasize the potential importance of routine
measurement of central BP in research and clinical settings.
Radial artery applanation tonometry is an established
methodology for noninvasive measurement of central BP
and has been widely used for research. It involves the use of
a generalized transfer function to derive a central BP wave-
form from the measured tonometry signal [7,8]. However,
the technique requires both a moderate level of operator
skill and also requires calibration by conventional sphyg-
momanometry. Furthermore, the mode of calibration has
been reported to influence the results considerably [9]. A
second option is a new, automatic, noninvasive, cuff-basedorized reproduction of this article is prohibited.
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(cSBP) from suprasystolic waveforms [10] as part of a
routine brachial BP measurement.
In this study, we compared noninvasive estimates of
central BP calculated by the cuff-based device and by
applanation tonometry in a multiethnic cohort of older
individuals with varying levels of cardiovascular risk.
In addition, we compared the cuff-based measurements
against invasive measurements of central aortic BP in a
small sample of patients with established disease.
MATERIALS ANDMETHODS
Participating patients
Noninvasive measurements were performed on 1107
participants aged 70 6 years recruited from the Southall
And Brent REvisited (SABRE) study. SABRE is a large
population-based tri-ethnic longitudinal study consisting
of white Europeans, first-generation migrant South Asians
and African-Caribbean people living in the UK. Participants
were originally recruited from primary care without exclu-
sions in 1988–1991 [11], and data for the current study were
collected as part of the 20-year follow-up that was con-
ducted between June 2008 and March 2011. Approval was
obtained from the local research ethics committee, and all
participants gave written informed consent. The study
adheres to the principles of the Declaration of Helsinki.Preliminary clinical assessment
All participants fasted overnight and refrained from taking
any medication on the morning of their visit to the clinic.
A questionnaire was completed, which detailed health
behaviours, medical history and medication. Height, weight
and waist circumference were measured, as previously
described [11]. Coronary heart disease (CHD) was defined
as a coronary event or revascularization identifiedbymedical
record review, and adjudicated by an independent commit-
tee. Fasting blood plasma and serum samples were taken for
biochemical analysis and those without known diabetes
also had an oral glucose tolerance test (OGTT) performed.
Diabetes was defined according to the 1999 WHO guidelines
[12], and hypertension was defined as physician-diagnosed
hypertension or participant-reported hypertension accom-
panied by receipt of BP-lowering medication.Noninvasive estimates of central blood
pressure
Participants rested in a sitting position in a quiet, dark,
temperature-controlled room for at least 10 min prior to
measurements. We performed two noninvasive measure-
ments of pressure (in the left brachial and radial arteries).
For these, we used a cuff-based device (Pulsecor R6.5;
Auckland, New Zealand) and a tonometry-based device
(SphygmoCor; AtCor, Sydney, Australia).
A variety of different cuff sizes were available to use with
the cuff-based device. Arm circumference was measured
prior to choosing which cuff to use according to the British
Society of Hypertension guidelines. The cuff-based device
was calibrated by recording BP in the brachial artery using
oscillometry employing a British Society of HypertensionCopyright © Lippincott Williams & Wilkins. Unaut
866 www.jhypertension.comvalidated algorithm [13]; details about the device and algor-
ithms have been published [10]. The cuff was then deflated
for 3–5 s, and reinflated to nearly 30 mmHg above the
recorded brachial systolic pressure (i.e. suprasystolic pres-
sure), to occlude the brachial artery. The resulting wide-
band suprasystolic cuff pressure signals were recorded for
10 s (approximately two respiratory cycles) before cuff
deflation. The device calculated central BP measurements
from the ensemble-averaged suprasystolic brachial cuff
waveforms calibrated to brachial BP as described pre-
viously [10,14].
SphygmoCor measurements were acquired immediately
after taking the Pulsecor measurements, according to the
manufacturer’s instructions. First, calibration was per-
formed using the measurements of BP acquired by the cuff
device. Two different calibration schemes were used: bSBP
and brachial diastolic BP (bDBP); and calibration using
brachial mean arterial pressure (MAP) and bDBP, where
MAP ¼ bDBP þ (0.4 pulse pressure), as described by Bos
et al. [15]. The SphygmoCor device is a hand-held tonom-
eter with a strain gauge pressure sensor; it was used to
applanate the left radial artery and record pressure wave-
forms over at least six cardiac cycles. Central BP was
calculated using the manufacturer’s software, which
employs a generalized transfer function.Repeatability and reproducibility of cuff-based
estimates of central blood pressure
Short-term repeatability data for the cuff-based device
was collected on 28 volunteers average age 53 20 years
(20 men) by recording two measurements 5–10min apart
on the same day. Long-term reproducibility was performed
on a different set of 28 individuals, average age 71 5 years
(23 men): measurements were repeated on two occasions
that were separated by an interval of approximately 1 month.Comparison with invasive central blood
presure measurements
In the invasive study, six patients (four men, aged 65 20
years) undergoing diagnostic catheterization procedures in
the Cardiac Catheterization Unit, Hammersmith Hospital,
London, UK, participated. The protocol was approved by
the local research ethics committee, met with the require-
ments of the Research Governance Framework and all
participating patients gave informed consent.
Invasive and noninvasive central BP was measured
simultaneously over a period of seven to 10 cardiac cycles.
Noninvasive estimates of central BP were derived using the
Pulsecor device, as described previously. Invasive ascend-
ing aortic pressure measurements were recorded using a
high-fidelity pressure wire (Combowire XT Guidewire;
Volcano Europe BVBA, Brussels, Belgium), which was
calibrated prior to each measurement. The raw data
were passed from the transducer into a Wavemap
console in which the analogue signal was converted into
a digital signal by a 12-bit analogue-to-digital converter.
Aortic pressure signals were processed off-line using
custom-written software in Matlab (The MathWorks Inc.,
Natick, Massachusetts, USA), and seven to 10 cycles were
analysed. The beats in the invasively measured pressurehorized reproduction of this article is prohibited.
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Cuff-based estimates of central blood pressurecorresponding to the beats used to calculate the cuff-based
pressure were identified and ensemble averaged off-line.
The form factor for both waveforms was calculated for
each patient as form factor¼ (MAP – bDBP)/pulse pressure
[16].
Statistical analysis
Statistical analyses were performed using Stata 12.0
(StataCorp, College Station, Texas, USA). All numerical
measurements are reported as mean SD. The data were
examined for skewness and were log-transformed if
necessary: the repeatability and reproducibility of data
from the brachial cuff-based device, comparison of cuff-
based and tonometry-based central BP estimates, and
comparison of cuff-based estimate vs. invasive pressures
were each performed using Bland–Altman analysis [17].
Repeatability and reproducibility were also assessed using
the within-individual coefficient of variation. Comparisons
of cSBP measured by the two devices were also assessed
using intraclass correlation coefficients (ICCs). Compari-
sons of cSBP estimated by the two noninvasive devices in
subgroups stratified by age, ethnicity, diabetes, hyperten-
sion, CHD and type of antihypertensive medication (in
those with known hypertension) were made using Stu-
dent’s t-test or analysis of variance (ANOVA) as appropri-
ate. Agreement between the waveforms of the ensemble
averages of the invasively measured pressures and cuff-
based measurements was determined by the cross-corre-
































































y = 0 is line of perfect average agreement
Observed average agreement 95% limits of agreement
FIGURE 1 Comparison of the repeatability and reproducibility of central systolic (cSBP) a
of cSBP; (b) repeatability of cDBP; (c) reproducibility of cSBP; (d) reproducibility of cDBP.
Journal of Hypertensionpatient. A P-value of less than 0.05 was considered stat-
istically significant.
RESULTS
Cuff-based device repeatability and long-term
reproducibility
The difference between the two estimates of the cSBP taken
5–10 min apart was 1 4mmHg and that of the cDBP was
0 4mmHg (Fig. 1a, b). The intraobserver coefficient of
variability was 4% for bSBP and 5% for bDBP, 4% for cSBP
and 5% for cDBP.
The average difference between the two estimates taken
1 month apart was 0 11mmHg for cSBP and 2 11mmHg
for cDBP (Fig. 1c, d). The coefficient of variability was 7%
for bSBP and 8% for bDBP and 8% for cSBP and 13% for
cDBP.
Comparison of cuff-based and tonometry-based
central blood pressure estimates
The characteristics of the 1107 participants in the non-
invasive study are presented in Table 1. Average resting
brachial BP was 142/84mmHg and 67% of participants
were taking antihypertensive therapy. Comparison of the
cSBP estimated using the tonometer (calibrated with the
bSBP and bDBP) and the cuff-based device revealed that
the cSBP was 3 6mmHg higher when measured using the
cuff-based device (Table 2, Fig. 2a). This value is within the

































































y = 0 is line of perfect average agreement
Observed average agreement 95% limits of agreement
nd diastolic (cDBP) pressure obtained using the cuff-based device. (a) repeatability
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TABLE 1. Characteristic of participants in noninvasive study
(n¼1107)
Variable Value
Men, n (%) 840 (76)
Age (years) 706
Ethnicity (European/South Asian/
African Caribbean), n (%)





Brachial systolic BP (mmHg) 14216
Brachial diastolic BP (mmHg) 8410
Heart rate (beats/min) 682
Antihypertensive treatment, n (%) 739 (67)
CHD, n (%) 271 (25)
Diabetes, n (%) 342 (31)














































































FIGURE 2 Comparison of central systolic pressure (cSBP) obtained using the cuff-
based device and tonometry calibrated using brachial systolic and diastolic pressure.
Park et al.Instrumentation (AAMI) standards (mean <5mmHg, or SD
<8mmHg). The cDBP did not differ between the two
noninvasive devices (Table 2, Fig. 2b). When the tonometer
was calibrated using the MAP and bDBP, the cuff-based
estimates of cSBP were 5 8mmHg lower than tonometry
estimates (Table 2, Fig. 3).
Stratified comparison of cuff-based and
tonometry-based central blood pressure
estimates
A more detailed assessment of the comparability of the
estimates of the cSBP obtained using the two noninvasive
devices was achieved by stratifying the patients according
to their sex, age more than 69 years, ethnicity, BMI, hyper-
tension status, diabetes status, presence of diagnosed CHD
and class of antihypertensive medication. Table 3 shows
that all comparisons still fell within the AAMI standards.
The differences between the two devices were not signifi-
cantly different when stratified by age, sex, ethnicity,
obesity, hypertension and CHD (Table 3). However,
there was a larger difference in the estimates of the cSBP
produced by the cuff-based device and tonometry in
participants with diabetes (P¼ 0.002) and a progressively
larger difference in overweight and obese individuals
(P¼ 0.003). Differences between cuff-based device and
tonometry in people with diabetes were similar when they
were stratified into normal overweight or obese categories
(data not shown), suggesting that the influence of diabetesCopyright © Lippincott Williams & Wilkins. Unaut
TABLE 2. Comparison of noninvasive central blood pressure measure
Variable




MAP (mmHg) 10411 14 7, 8
cDBP (mmHg) 8510 02 4, 5
cSBP (mmHg) 13216 36 8, 14
Central PP (mmHg) 4813 25 8, 11
All data are presented as mean SD, mean difference SD of difference (Meandiff SDdiff) and
pressure; cSBP, central systolic pressure; MAP, mean arterial pressure; PP, pulse pressure.
868 www.jhypertension.comwas not attributable to more obese participants in the
group with diabetes.
Comparison of noninvasive cuff-based and
invasive pressure waveforms
The average resting brachial BP for the invasive study
participants (n¼ 6, 67% men) was 126/82mmHg. Figure
4a shows the ensemble average of the invasively measured
pressure and noninvasive pressure waveforms for one of
the participants. In all patients, the cSBP tended to be
higher, whereas the cDBP was significantly lower in inva-
sive than in noninvasive measurements. Figure 4b showshorized reproduction of this article is prohibited.
ments (n¼1107)




0.94 10711 23 7, 3 0.95
0.98 8510 02 3, 4 0.99
0.91 14117 58 20, 10 0.85
0.88 5616 59 22, 11 0.77
limits of agreement and intraclass correlation coefficients (ICC). cDBP, central diastolic








































FIGURE 3 Comparison of central systolic pressure (cSBP) obtained using the cuff-
based device and tonometry calibrated using brachial mean and diastolic pressure.
Cuff-based estimates of central blood pressurethe normalized pressure waveforms obtained from the
same patient. In this case, the noninvasively acquired
cuff-based pressure waveforms correlated closely with
the normalized invasively acquired waveform with a
cross-correlation coefficient of 0.93.
The average difference between the invasively and non-
invasively estimated cSBP was 5 8 mmHg (P¼ 0.2;
Table 4), while that for cDBP was 8 3mmHg
(P< 0.001). The mean aortic pressure difference over the
cardiac cycle between the noninvasive and invasively
measured data was  3mmHg (P¼ 0.6). The average
cross-correlation coefficient between noninvasive and
invasive waveforms was 0.97 0.02. The form factor wasCopyright © Lippincott Williams & Wilkins. Unauth
TABLE 3. Comparison of central systolic blood pressure (cSBP) meas




























Data are mean differences SD of difference and (limits of agreement) for cuff cSBP- tonometr
groups were made using a Student’s t-test or analysis of variance (ANOVA). A P value of <0.05
ARB, angiotensin receptor blocker; CCB, calcium channel blocker; CHD, coronary heart disease.
Journal of Hypertensionlower for the noninvasively measured data (0.39 0.01)
than for invasively measured data (0.47 0.05).
DISCUSSION
Measurement of central BP appears to offer advantages
over brachial BP for risk stratification [4,6] and assessment
of therapeutic efficacy [5]. If it is to be widely adopted in the
clinic, devices that estimate central BP should be easy
to operate, reproducible and accurate. Analysis of a large
data set from a multiethnic population-based study pro-
vided evidence that the new cuff-based technique was
easy to use, reproducible and gave similar results to
applanation tonometry. In a small study, the noninvasive
cuff-based device also gave acceptably accurate estimates
of central pressure waveforms compared with invasive
aortic measurements.
Tonometry is regarded as the ‘gold standard’ method for
noninvasive measurement of central BP [4,18–20]. How-
ever, it has been well documented that, when calibrated
with brachial systolic and diastolic pressures, tonometry
underestimates invasively measured cSBP by nearly
4–13 mmHg [21–23]. Recalibration of the data using MAP
and bDBP has been reported to reduce these differences
[15]. With respect to our noninvasive study, the agreement
between the cSBP estimated by the two devices was accept-
able when using either bSBP/bDBP or MAP/bDBP [15] to
calibrate the tonometry device. These results are in agree-
ment with those of Climie et al. [14] who found a mean
difference standard deviation in cSBP of 1 2mmHg
comparing Pulsecor and Sphygmocor devices in a smallorized reproduction of this article is prohibited.

























y cSBP (calibrated using brachial systolic and diastolic pressure). Comparisons of stratified
was considered statistically significant. ACEI, angiotensin-converting enzyme inhibitor;
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Ensemble average invasive pressure vs central pressure pulseCor

























Normalised ensemble average invasive pressure vs central pressure pulseCor
0.6 0.7 0.8 0.9 1
Normalised aortic pressure (invasive)
Normalised central pressure (non-invasive)
Aortic pressure (invasive)
Central pressure (non-invasive)
FIGURE 4 Ensemble average invasive pressure vs. cuff-based device derived central pressure. (a) Invasive aortic (red) and noninvasive (blue) central pressure waveforms
acquired in the same patient. (b) Normalized pressure waveforms acquired from the same patient.
TABLE 4. Comparison of cuff-based estimates of central blood pressure and invasively acquired aortic measurements (n¼6)
Noninvasive Invasive Difference (noninvasive – invasive) P
cSBP (mmHg) 12116 12623 58 0.2
cDBP (mmHg) 8312 7510 83 <0.001
MAP (mmHg) 9813 9916 13 0.6
All data are presented as mean SD or mean difference SD of the difference. cDBP, central diastolic pressure; cSBP, central systolic pressure; MAP, mean arterial pressure.
Park et al.
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Cuff-based estimates of central blood pressuresample of younger individuals. The results of our present
study stress the importance of correctly calibrating the
tonometry device [24], although they do not resolve the
question of which calibration method is superior.
Several noninvasive devices have been designed to
estimate cSBP. Such systems include a modified tonom-
eter sensor embedded into a wrist strap (BPro), brachial
oscillometric devices that incorporate the transfer func-
tion method (Mobil-O-Graph, SphygmoCor XCEL,
WatchBP Office, Vicorder, CardioMon) and those that
adopt an occlusive cuff ‘stop-flow’ approach similar to
that adopted by the Pulsecor (Arteriograph). All these
systems have been tested and show potential. Brachial
cuff-based approaches do not require separate calibra-
tion and circumvent problems related to brachial-radial
amplification. Moreover, learning to operate the device
requires little additional training beyond the training in
the measurement of BP. However, these devices cannot
overcome the inherent inaccuracy of cuff-based tech-
niques [25,26].
This study expands on previous work by comparing
noninvasively obtained pressure waveforms with aortic
pressure waveforms measured invasively with high-fidelity
catheters. Noninvasive estimates of cSBP were nearly
5mmHg lower than measured aortic SBP, whereas esti-
mated central DBP was 8 mmHg higher than aortic DBP.
These findings are consistent with previous studies show-
ing average differences of 8–18mmHg comparing non-
invasive and invasive DBP [25,26]. Form factors were
higher for invasively measured data, although in both cases,
the values were within the range (0.35–0.53) reported by
Chemla et al. [27] for central BP. Both the systolic upstroke
and the diastolic decay of the invasively and noninvasively
acquired pressure waveforms showed excellent agreement,
but agreement of the waveforms around the dicrotic notch
was less good. This may be a consequence of damping of
the signal due to the properties of arm tissue and cuff and/
or effects due to ensemble averaging cardiac cycles with
inherently variable ejection periods. Despite this limitation,
the fidelity of the central pressure waveforms was accept-
able.
There are several strengths to this study: it used a large
population-based cohort, which included men and women
of varying ethnicities, age and cardiovascular health. The
agreement between the two devices remained high when
stratified by age, sex, ethnicity, obesity, hypertension, diag-
nosed CHD and antihypertensive medication class. The
largest interdevice differences were observed in partici-
pants with diabetes; however, these differences were small
and still fell within the AAMI standards. A possible expla-
nation for the increased difference in people with diabetes
is that the generalized transfer function used by the ton-
ometer to derive central BP may be less accurate in diabetes
due to increased arterial stiffness/calcification. Concerns
regarding inaccuracies in the transfer function for deriving
central BP in patients with diabetes mellitus have been
raised previously [28].
A possible limitation to the noninvasive study was that
the devices were not used in a randomized order. The
cuff-based device was always used first to allow calibration
to be performed. However, the cuff-acquired brachial BPCopyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionmeasurement was used to calibrate the tonometer and
patients were well rested before any measurements were
taken. A further limitation is the age of our cohort. We only
compared the devices in older individuals; consequently,
our findings may not necessarily apply to a younger popu-
lation. The main limitations for the invasive study were the
small number of participants and the lack of simultaneous
tonometry data.
In conclusion, cSBP obtained from noninvasive cuff-
based measurements of brachial pressure showed accept-
able agreement with estimates based on radial tonometry. A
cuff-based device requires minimal additional training and
may facilitate measurement of central pressure in trials,
observational studies and the clinic.
Central BP may be a superior predictor of cardiovascular
events and is differentially influenced by antihypertensive
therapy. We show that a brachial cuff-based device pro-
vides reliable and accurate estimates of central BP. This
approach could facilitate adoption of measurement of
central BP in clinical practice.
ACKNOWLEDGEMENTS
We would like to thank the SABRE participants and SABRE
team.
SABRE was funded by the Wellcome Trust (082464/2/07/
2) and the British Heart Foundation (SP/07001/23603 and
PG 08 103). O.K. received funding from the Foundation for
Circulatory Health. A.H. and N.C. received support from the
National Institute for Health Research (NIHR) Biomedical
Research Centre based at Imperial College Healthcare NHS
Trust and Imperial College London.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific
relevance of usual blood pressure to vascular mortality: a meta-analysis
of individual data for one million adults in 61 prospective studies.
Lancet 2002; 360:1903–1913.
2. Salans AH. A study of the central and peripheral arterial pressure pulse
in man: correlation with simultaneously recorded electrokymograms.
Circulation 1951; 4:510–521.
3. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method
for estimating ascending aortic pressure from the radial artery pressure
waveform. Hypertension 2001; 38:932–937.
4. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al.
Central pressure more strongly relates to vascular disease and outcome
than does brachial pressure: the Strong Heart Study. Hypertension
2007; 50:197–203.
5. Manisty CH, Hughes AD. Meta-analysis of the comparative effects of
different classes of antihypertensive agents on brachial and central
systolic blood pressure, and augmentation index. Br J Clin Pharmacol
2013; 75:79–92.
6. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K,
Stefanadis C. Prediction of cardiovascular events and all-cause
mortality with central haemodynamics: a systematic review and
meta-analysis. Eur Heart J 2010; 31:1865–1871.
7. Karamanoglu M, O’Rourke MF, Avolio AP, Kelly RP. An analysis of the
relationship between central aortic and peripheral upper limb pressure
waves in man. Eur Heart J 1993; 14:160–167.
8. Chen C-H, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan WL, et al.
Estimation of central aortic pressure waveform by mathematical trans-
formation of radical tonometry pressure: validation of generalised
transfer function. Circulation 1997; 95:1827–1836.orized reproduction of this article is prohibited.
www.jhypertension.com 871
Park et al.9. Segers P, Mahieu D, Rietzschel ER, De Buyzere M, Van Bortel L. Impact
of radial artery pressure waveform calibration on estimated central
pressure using a transfer function approach. Hypertension 2008; 52:
e24–e25.
10. Lowe A, Harrison W, El-Aklouk E, Ruygrok P, Al-Jumaily AM. Non-
invasive model-based estimation of aortic pulse pressure using supra-
systolic brachial pressure waveforms. J Biomech 2009; 42:2111–2115.
11. Tillin T, Forouhi NG, McKeigue PM, Chaturvedi N. Southall And Brent
REvisited: Cohort profile of SABRE, a UK population-based compari-
son of cardiovascular disease and diabetes in people of European,
Indian Asian and African Caribbean origins. Int J Epidemiol 2012;
41:33–42.
12. World Health Organization. Definition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and classi-
fication of diabetes mellitus. Geneva: WHO; 1999.
13. Jones C, Taylor K, Poston L, Shennan A. Validation of the Welch Allyn
’Vital Signs’ oscillometric blood pressure monitor. J Hum Hypertens
2001; 15:191–195.
14. Climie RE, Schultz MG, Nikolic SB, Ahuja KD, Fell JW, Sharman JE.
Validity and reliability of central blood pressure estimated by upper
arm oscillometric cuff pressure. Am J Hypertens 2012; 25:414–420.
15. Bos WJ, Verrij E, Vincent HH, Westerhof BE, Parati G, van Montfrans
GA. How to assess mean blood pressure properly at the brachial artery
level. J Hypertens 2007; 25:751–755.
16. Segers P, Mahieu D, Kips J, Rietzschel E, De BM, De BD, et al.
Amplification of the pressure pulse in the upper limb in healthy,
middle-aged men and women. Hypertension 2009; 54:414–420.
17. Bland JM, Altman DG. Measuring agreement in method comparison
studies. Stat Methods Med Res 1999; 8:135–160.
18. O’Rourke MF, Adji A. Noninvasive studies of central aortic pressure.
Curr Hypertens Rep 2012; 14:8–20.
19. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D,
et al. Differential impact of blood pressure-lowering drugs on centralCopyright © Lippincott Williams & Wilkins. Unaut
872 www.jhypertension.comaortic pressure and clinical outcomes: principal results of the Conduit
Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213–
1225.
20. McEniery CM, Yasmin. McDonnell B, Munnery M, Wallace SM, Rowe
CV, et al. Central pressure: variability and impact of cardiovascular risk
factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 2008;
51:1476–1482.
21. Cloud GC, Rajkumar C, Kooner J, Cooke J, Bulpitt CJ. Estimation of
central aortic pressure by SphygmoCor requires intra-arterial peri-
pheral pressures. Clin Sci (Lond) 2003; 105:219–225.
22. Rajani R, Chowienczyk P, Redwood S, Guilcher A, Chambers JB. The
noninvasive estimation of central aortic blood pressure in patients with
aortic stenosis. J Hypertens 2008; 26:2381–2388.
23. Zuo JL, Li Y, Yan ZJ, Zhang RY, Shen WF, Zhu DL, et al. Validation of
the central blood pressure estimation by the SphygmoCor system in
Chinese. Blood Press Monit 2010; 15:268–274.
24. Mahieu D, Kips J, Rietzschel ER, De Buyzere ML, Verbeke F, Gillebert
TC, et al. Noninvasive assessment of central and peripheral arterial
pressure (waveforms): implications of calibration methods. J Hypertens
2010; 28:300–305.
25. Guilcher A, Brett S, Munir S, Clapp B, Chowienczyk PJ. Estimating
central SBP from the peripheral pulse: influence of waveform analysis
and calibration error. J Hypertens 2011; 29:1357–1366.
26. Smulyan H, Siddiqui DS, Carlson RJ, London GM, Safar ME. Clinical
utility of aortic pulses and pressures calculated from applanated radial-
artery pulses. Hypertension 2003; 42:150–155.
27. Chemla D, Hbert JL, Aptecar E, Mazoit JX, Zamani K, Frank R, et al.
Empirical estimates of mean aortic pressure: advantages, drawbacks
and implications for pressure redundancy. Clin Sci 2002; 103:7–13.
28. Hope SA, Tay DB, Meredith IT, Cameron JD. Use of arterial transfer
functions for the derivation of central aortic waveform characteristics in
subjects with type 2 diabetes and cardiovascular disease. Diabetes Care
2004; 27:746–751.Reviewers’ Summary Evaluations
Reviewer 1I
n a large and heterogeneous cohort of subjects with
different levels of cardiovascular risk, the authors
compared two noninvasive methods for measuring
central BP (a cuff-based device and applanation tonom-
etry). The cuff-based method was found to be easy to
use, as well as reproducible and accurate in most
patients.
As strengths of this study count the population included
and the rigorous methods used; the results are interesting
and for sure a good base for future studies.
Weaknesses: the data could not be extended for subjects
younger than the population included (70 6 years). Theinter-device difference in diabetic patients needs further
investigations.
Reviewer 2
The authors have conducted an elegant study in a broad
population of 1107 individuals, on noninvasive central
blood pressure using a technique easier to apply in clinical
practice, and less dependence on the ability of the
researcher or clinician that will measure blood pressure,
so it is of interest for application in clinical practice.
Among the weaknesses of this study should be noted that
it was conducted in an aging population, so the results
cannot be extrapolated to younger population. Moreover,
the invasive study was conducted in a very small number of
subjects.horized reproduction of this article is prohibited.
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